Cowen bullish on Privia Health Group, upgrades to 'outperform'

Privia Health

22/02/2022 12:34

** Cowen upgrades tech-driven healthcare services firm
 PRVA.O  to 'outperform' from 'market perform' 
    ** Expects Privia Health to benefit from the recent
expansion into California and West Texas markets in the
near-term 
    ** "The company's growth trajectory, sales momentum,
positive FCF and strong balance sheet are attractive at current
valuations" - Cowen 
    ** Brokerage says co's target of 20% annual growth in gross
practice collections over the intermediate term is achievable 
    ** The brokerage has a PT of $35 on the stock, which implies
an upside of 56.7% to PRVA's last close  
    ** Consensus rating of 10 analysts on the stock is 'buy';
their median PT is $43 - Refinitiv data
    ** As of last close, stock had fallen 13.68% so far this
year

 (Reporting by Manya Saini in Bengaluru)
 ((Manya.Saini@thomsonreuters.com;))